Rights and permissions
About this article
Cite this article
Initiating exenatide cost saving vs insulin in the US. Pharmacoecon. Outcomes News 651, 7 (2012). https://doi.org/10.2165/00151234-201206510-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206510-00016